Sofinnova Partners
www.sofinnovapartners.comVCMatch tracks Sofinnova Partners as an investor focused on Biotech, Medtech, and Digital Health companies, Seed and Series A rounds, Europe, France, and Italy markets, and $11m to $76m check sizes. Upload your deck to compare your startup against the full private matching profile.
Check Size
$11m to $76m
Focus Areas
Geography
Europe, France, and Italy
Investment Thesis
Sofinnova Partners believes in investing in breakthrough innovations that solve the world’s most pressing problems. Their core philosophy centers on the conviction that treating patients and saving lives creates positive investor returns: ‘If you treat patients, you save lives, ultimately this is going to be good for investors. We believe that by backing companies, whether early stage or later stage, that bring a product to patients — ultimately this translates into financial return.’ They emphasize that sustainable growth can be achieved in parallel with attractive financial returns, viewing ethical business practices and environmental stewardship as compatible with strong financial performance.
Is Sofinnova Partners right for your startup?
Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.
Investment Focus
Who should take a closer look
Sofinnova Partners is most relevant for founders raising Seed, Series A, and Series B rounds in Biotech, Medtech, Digital Health, and Healthtech, especially across Europe, France, and Italy, with public check-size signals around $11m to $76m.
Focus statement
Sofinnova Partners focuses on breakthrough innovations in biopharma, medtech, digital medicine, agriculture, and industrial biotech that contribute to people's health and well-being. They are active across the entire life sciences value chain from seed to later-stage investments, with particular emphasis on companies that have the potential to become market leaders.
Value Add
- Known for being 'company creators' - they launch early-stage companies through dedicated accelerators (MD Start and Biovelocita)
- Multi-fund platform with 7 specialized investment strategies and dedicated teams for different stages and sectors
- 50+ years of experience (founded 1972) having backed 500+ companies and created numerous market leaders globally
- Over €4 billion in assets under management providing significant resources and network
- 'Partners for Life' cornerstone - building lasting relationships with trust and transparency
- Hands-on, operational approach to company building rather than passive investment
- Strong European presence and leadership, particularly in industrial biotech sustainability solutions
Stage And Sector Fit
Ready to find your perfect investor match?
Get Started Free